ORIGINAL RESEARCH article
Front. Nutr.
Sec. Clinical Nutrition
Volume 12 - 2025 | doi: 10.3389/fnut.2025.1577563
Comparing 11 Nutrition-Inflammation Indices for Perioperative Management and Prognostic Evaluation in Non-Small Cell Lung Cancer Patients
Provisionally accepted
- First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Despite the establishment of multiple nutrition-inflammation indices, their performances in guiding clinical decision-making have not been systematically compared in patients with non-small cell lung cancer (NSCLC). This study aimed to identify the best nutrition-inflammation index for facilitating perioperative management and prognosis analysis in NSCLC patients.Methods: This study included NSCLC patients who underwent video-assisted thoracoscopic lobectomy as their primary treatment. Nutrition-inflammation indices were calculated based on blood tests and anthropometric measurements conducted within one week prior to surgery. A total of 11 nutrition-inflammation indices were compared for their performance in predicting perioperative and survival outcomes.The cohort consisted of 805 patients, with a mean age of 60.3 years, including 388 females (48.2%) and 417 males (51.8%). Postoperative complications occurred in 152 patients (18.9%). The median follow-up time after surgery was 64.5 months. Most nutrition-inflammation indices demonstrated predictive values for perioperative complications, delayed hospital discharge, and survival outcomes, but with relatively low predictive accuracy. After adjusting for clinicopathological characteristics, most indices were no longer associated with these therapeutic outcomes. Among these indexes, the lymphocyte-to-monocyte ratio showed the best performance in predicting perioperative complications and delayed hospital discharge, while the geriatric nutritional risk index showed the best performance in predicting overall survival and disease-free survival.The current nutrition-inflammation indices demonstrated predictive values for therapeutic outcomes in NSCLC patients, but their utility in clinical practice may be limited due to generally weak independent associations. Future studies should focus on exploring more comprehensive nutrition-inflammation biomarkers for assisting clinical decision-making.
Keywords: Non-small cell lung cancer, nutrition, Inflammation, Surgery, Perioperative management, Survival
Received: 16 Feb 2025; Accepted: 20 May 2025.
Copyright: © 2025 Wang, Zhang, Li, Zhang, Wang and Wu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Jing Wang, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
Qiuge Wu, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.